SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology (GRRR) is trending as investors debate whether a new $500 million AI infrastructure deal with Yotta Data Services validates the company's growth trajectory or signals continued reliance on unconfirmed, high-value contracts. While bulls emphasize strong insider ownership, recent incentive plans, and a massive project pipeline, the community remains divided by ongoing skepticism regarding past deal transparency, potential dilution, and the company's ability to convert these major announcements into consistent revenue.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is gaining traction as a permissionless brand-coin, with the community actively driving development through various real-world product initiatives like energy drinks, apparel, and racing gear. Holders emphasize the project's organic growth and the collaborative, entrepreneurial spirit of the community as key reasons for their ongoing conviction.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is under intense scrutiny as investors weigh strong earnings and foundry demand against persistent concerns over China export restrictions and tariff risks. The community remains deeply divided, with many focusing on the stock's recent volatility and the potential for guidance updates to drive its next major technical move.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is drawing significant investor attention due to its aggressive AI infrastructure expansion in Europe, highlighted by a major new data center facility in Finland that supports its ambitious long-term capacity targets. While community sentiment remains largely bullish, pointing to the company's strong execution and strategic hyperscaler partnerships, the stock is currently facing volatility and profit-taking pressure alongside the broader AI and memory sectors as investors re-evaluate positions at the end of the quarter.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant downward pressure as market sentiment sours amid broader semiconductor sector weakness, rising geopolitical tensions in the Middle East, and speculative concerns over the impact of Google's memory-compression algorithm on future hardware demand. The community is deeply divided between long-term bulls highlighting Micron's historically low forward P/E and solid fundamentals, and bearish participants pointing to technical breakdowns and fears that the current memory cycle has peaked.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently the focal point of intense community debate, driven by a high-stakes mix of aggressive Bitcoin accumulation strategies and concerns over ongoing equity dilution. Traders are actively clashing over the company's long-term sustainability versus its role as a leveraged proxy for crypto, with sentiment deeply split between those anticipating a major breakout and those bracing for further downside.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending as shareholders digest a cryptic message from CEO Dr. Patrick Soon-Shiong regarding balance sheet strengthening, which has sparked intense debate over potential capital raising versus strategic global expansion. While some retail investors express frustration over recent stock volatility and class-action headlines, the community remains heavily focused on the company's international prospects, including potential deals in Saudi Arabia and the EU as an alternative to ongoing domestic regulatory friction.

Tower Semiconductor Ltd. engages in providing semiconductor solutions. It also offers technology and manufacturing platforms for integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, mobile, infrastructure, medical, and aerospace and defense. It focuses on creating positive and sustainable impact on the world through long term partnerships and its advanced and innovative analog technology offering, comprised of a broad range of customizable process platforms such as SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, non-imaging sensors, integrated power management (BCD and 700V), and MEMS. Its designs enable a quick and accurate design cycle as well as process transfer services including development, transfer, and optimization, to IDMs and fabless companies. The company was founded in 1993 and is headquartered in Migdal Haemek, Israel.

Tower Semiconductor Ltd.

Tower Semiconductor is currently in the spotlight as investors await a final resolution regarding the long-pending acquisition by Intel, with market sentiment heavily pressured by the potential for a deal termination due to lingering regulatory hurdles in China. The community is actively debating the stock's standalone valuation and whether the significant termination fee potentially headed to the company provides a sufficient safety net against further downward volatility.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently attracting significant institutional attention following a major institutional buy of long-term call options, signaling high conviction despite the stock's recent pullback from its highs. While the community remains divided over whether to treat the current levels as a 'falling knife' or a strategic entry point, sentiment is fueled by broader debates around semiconductor supply chain bottlenecks and institutional confidence in the long-term AI hardware cycle.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta ($KTA) is trending as the community debates its long-term potential as a high-speed financial infrastructure network, with many users actively accumulating during recent volatility. Discussions are heavily focused on high transaction throughput claims, upcoming exchange listings, and speculative partnerships that supporters believe will drive a major re-rating of the token.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new clinical and real-world data from its cardiovascular (CV) portfolio presented at the American...

Assenagon Asset Management S.A. Sells 54,791 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Assenagon Asset Management S.A. trimmed its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 68.2% during the fourth quarter, according to the company in its most recent 13F...

Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SG Americas Securities LLC Buys 59,071 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

SG Americas Securities LLC increased its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 185.5% in the 4th quarter, according to its most recent disclosure with the...

Chardan Capital Reaffirms "Buy" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)

Chardan Capital reissued a "buy" rating and set a $425.00 price target on shares of Alnylam Pharmaceuticals in a report on Wednesday...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Given "Buy" Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $510.00 price objective on shares of Alnylam Pharmaceuticals in a research note on Wednesday...

Alnylam Pharmaceuticals Touts AMVUTTRA ATTR-CM Momentum, Raises 2026 TTR Revenue Outlook

Alnylam Pharmaceuticals (NASDAQ:ALNY) used a company webinar to highlight early commercial momentum for AMVUTTRA (vutrisiran) in ATTR cardiomyopathy (ATTR-CM), outline initiatives aimed at expanding diagnosis, and discuss how management views upcoming competitive and market-access dynamics in the ca...

Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced a set of strategic efforts designed to accelerate earlier recognition and improve care...

Congress Asset Management Co. Boosts Position in Alnylam Pharmaceuticals, Inc. $ALNY

Congress Asset Management Co. boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 126.6% in the fourth quarter, according to its most recent 13F filing with...

Hudson Bay Capital Management LP Lowers Holdings in Alnylam Pharmaceuticals, Inc. $ALNY

Hudson Bay Capital Management LP lowered its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 38.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,411 shares of the biopharma...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.96	--	--	N/A
Q4 '25	$1.16	$0.82	-29.06%	MISSED
Q3 '25	$0.56	$1.84	228.01%	BEAT
Q2 '25	-$0.54	-$0.51	6.20%	BEAT
Q1 '25	-$0.89	-$0.44	50.56%	BEAT

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc